Nuwellis, Inc. (NUWE)
Data as of , from SEC Form 4 filings.
See up to 3 months of NUWE. The 7-day demo opens the 1M and 3M ranges and puts NUWE on your watchlist.
Start 7-day demoLatest NUWE insider trades
- Gregory D. WallerGrant or award6,744 sh
Martin J. EmersonGrant or award6,744 sh
About Nuwellis, Inc. (NUWE)
Nuwellis, Inc. files with the SEC under CIK 0001506492 and is classified as electromedical and electrotherapeutic apparatus. It is grouped with Health Care companies on this site. It filed a registration statement with the SEC on 22 May 2026 and has not yet priced an offering.
NUWE Form 4 activity by transaction type, last 90 days
No Form 4 activity for NUWE in the last 90 days.
NUWE insider transactions (Form 4)
117 Form 4 filings on record, the earliest from May 20, 2025, newest first.
| Traded | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Gregory D. Waller | Grant or award | Nonstatutory Stock Option (right to buy) | 6,744 | $0.00 | - | |
| Martin J. Emerson | Grant or award | Nonstatutory Stock Option (right to buy) | 6,744 | $0.00 | - | |
 Archelle Georgiou Feldshon | Grant or award | Nonstatutory Stock Option (right to buy) | 6,744 | $0.00 | - | |
| David McDonald | Grant or award | Nonstatutory Stock Option (right to buy) | 6,744 | $0.00 | - | |
| John L. Erb - Officer | Grant or award | Incentive Stock Option (right to buy) | 115,329 | $0.00 | - | |
| John L. Erb - Officer | Other | Common Stock | 1,092,500 | $0.06 | $66K | |
| John L. Erb - Officer | Other | Common Stock | 7,522 | $0.06 | $451 | |
| John L. Erb - Officer | Other | Series F Convertible Preferred Stock | 100 | - | - | |
| John L. Erb - Officer | Other | Series F-1 Convertible Preferred Stock | 100 | - | - | |
| John L. Erb - Officer | Other | Series F-1 Convertible Preferred Stock | 66 | - | - | |
| Gregory D. Waller | Grant or award | Nonstatutory Stock Option (right to buy) | 17,496 | $0.00 | - |
NUWE insider trading FAQ
What is the latest insider trade for NUWE?
Nuwellis, Inc. (NUWE) has filed no insider reports in the last 90 days. The most recent on record is dated 30 April 2026. The full record for NUWE runs to 7 Form 4 filings, the earliest from 20 May 2025. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying NUWE stock?
No insider purchases of NUWE were filed in the last 90 days.
How many insiders are selling NUWE stock?
No insider sales of NUWE were filed in the last 90 days.
Where can I see NUWE SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects NUWE Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
7The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Gregory D. Waller view on EDGAR
- - Martin J. Emerson view on EDGAR
- - Archelle Georgiou Feldshon view on EDGAR
- - David McDonald view on EDGAR
- - John L. Erb view on EDGAR
- - John L. Erb view on EDGAR
- - Gregory D. Waller view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where NUWE's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow NUWE with a 7-day demo
- NUWE on your watchlist
- Every NUWE Form 4 filing on record
- Up to 3 months of NUWE price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
